Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenues $ 10,959 $ 299 $ 15,641
Cost of revenues 1,991 400 2,005
Gross profit (loss) 8,968 (101) 13,636
Operating expenses:      
Research and development 10,484 10,255 7,631
General, administrative and marketing 5,996 6,741 5,940
Total operating income (loss) (7,512) (17,097) 65
Financial income, net 493 172 172
Net income (loss) $ (7,019) $ (16,925) $ 237
Basic net income (loss) per ordinary share (in Dollars per share) $ (0.62) $ (1.53) $ 0.02
Diluted net income (loss) per ordinary share (in Dollars per share) $ (0.62) $ (1.53) $ 0.02
Weighted average number of ordinary shares used in computation of basic net income (loss) per share (in Shares) 11,389,168 11,033,310 9,968,972
Weighted average number of ordinary shares used in computation of diluted net income (loss) per share (in Shares) 11,389,168 11,033,310 11,966,788